-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqISIN US60770K1079-
Moderna IncBörse NasdaqISIN US60770K1079 WKN: A2N9D9Symbol MRNA
-
ModernaBörse Börse FrankfurtISIN US60770K1079 WKN: A2N9D9EURSymbol 0QF
-
ModernaBörse Börse BerlinEURSymbol 0QF
-
ModernaBörse Börse StuttgartEURSymbol 0QF
-
ModernaBörse Börse MünchenEURSymbol 0QF
-
ModernaBörse Börse HamburgEURSymbol 0QF
-
ModernaBörse Xetra FrankfurtEURSymbol 0QF
-
ModernaBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 0QF
-
ModernaBörse Quotrix System der Börse DüsseldorfEURSymbol 0QF
-
ModernaBörse Gettex System der Börse MünchenEURSymbol 0QF
-
ModernaBörse Börse DüsseldorfEURSymbol 0QF
-
ModernaBörse Bolsa Mexicana de Valore Mexiko-StadtMXNSymbol MRNA
-
Moderna, Inc.Börse BVMF
-
Moderna, Inc.Börse Bolsa Mexicana de Valore Mexiko-Stadt
-
Moderna, Inc.Börse London Stock Exchange
-
ISIN US60770K1079
WKN A2N9D9
Symbol MRNA
Börse
Nasdaq Zeitzone: Europe/Berlin
Mitarbeiter
3.900
Moderna underperformed den DAX um -39 % vom 11.08.2021 bis 31.12.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 117,86 USD +0,51%
Letzte Communitymeinungen
- Ein User war zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
Zockrat
29.08.2021
Ein User hat Moderna abonniert.
Aktionärsstruktur der Moderna
Portrait der Moderna Aktie
Das Unternehmen Moderna aus USA beschäftigt 3.900 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Die Moderna Aktie konnte seit dem 11.08.2021 leider keine Rendite erwirtschaften. Die Kursverluste lagen bei -38%.
Moderna ist in mehr als 39 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Moderna mit 12,47% im ETF.
Entdecke die 6 ETFs in denen Moderna am höchsten gewichtet ist Insgesamt in 39 ETFs enthalten
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
986 News & Informationen zur Moderna Aktie
Scarce doses and empty vaccination centres: Germany's vaccine rollout headache
Proud of
their national reputation for efficiency, Germans are growing
increasingly frustrated by the slow rollout of a COVID-19
vaccine its scientists helped develop.
Scarce vaccine… | January 10, 2021
ROUNDUP: Schrfere Corona-Regeln in weiteren Lndern – ber 530 000 Geimpfte
ROUNDUP: Schrfere Corona-Regeln in weiteren Lndern – ber 530 000 Geimpfte | Nachricht | finanzen.net
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week's J.P. Morgan Healthcare Conference.
After ending 2020 in …
Tumultuous 2020 rewards investors who stared down turmoil
THE bell has just tolled on one of the wildest years in Wall Street history, full of precipitous plunges, improbable rebounds and human tragedy. The S&P 500 ended on an upbeat, with a 1.4-percent gain in the holiday-shortened week. That pushed its 2020 gain to 16 percent, an ending that…
mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow
The best news about the mRNA shots from BioNTech and Moderna is that the same technique could also defeat many other diseases.
Moderna : vaccine set to arrive in France as country steps up anti-COVID drive
Moderna Inc's COVID-19
vaccine will arrive in France on Monday, French Prime Minister
Jean Castex said, as the country steps up its vaccination drive
following a sluggish start.
Castex… | January 9, 2021
Pfizer, Moderna vaccines may vanquish Covid today, cancer tomorrow
Read more about Pfizer, Moderna vaccines may vanquish Covid today, cancer tomorrow on Business Standard. Ordinary vaccines tend to be inactivated or weakened viruses which, when injected into the body, stimulate an immune response that can later protect against the live pathogen
Biden plans accelerated release of Covid-19 vaccine to states as pandemic hits hard
NEW YORK: President-elect Joe Biden may accelerate distribution of Covid-19 vaccines to US states, a spokesman said yesterday, in an effort to jump-st…
Biden Says He’ll Release More Vaccine In Gamble On Second Doses
(Bloomberg) — President-elect Joe Biden says he’ll distribute more of the available doses of coronavirus vaccines, reversing the Trump administration’s practice of holding back second doses to ensure they’re available for people who’ve already had their first shot.
20 Biggest Questions in Science
In this article we are going to list the 20 biggest questions in science. Click to skip ahead and jump to the 10 biggest questions in science. If your…
Biden plans to release more Covid vaccine doses in break from Trump administration policy
The initial rollout of the vaccines has been slower than expected, with the U.S. failing to hit the goal of vaccinating 20 million Americans in December.
FDA chief encourages states to open Covid vaccines to older Americans, other groups
The head of the FDA is urging states to begin vaccinating lower-priority groups against Covid-19 as officials try to pick up the pace of the vaccine rollout.
Sinovac jab is 78% effective in Brazil after data confusion
The vaccine developed by China’s Sinovac Biotech Ltd. was found to be 78 percent effective against Covid-19 in late-stage trials in Brazil, the most definitive evidence so far on the shot’s efficacy after previous data sparked doubt and confusion. The protection rate, confirmed by Sao Paulo state officials, was derived…
Dr. Gottlieb sees 30% of people in U.S. getting Covid and 10% vaccinated as of end of January
As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade
MRNA stock will continue to slide as its Covid-19 vaccine gains are priced in, and the competiton is chomping away at its market share.
Moderna’s Covid-19 Vaccine Is Authorized by U.K. Regulator
The U.K.’s health regulator authorized the use of Moderna’s Covid-19 vaccine, boosting the number of different shots at the country’s disposal to three as it battles a contagious new variant of the virus.
Europe's drug regulator says there is an extra dose in BioNTech/Pfizer's COVID-19 vaccine vials
The European Medicines Agency said Friday that the product information for BioNTech SE undefined and Pfizer Inc.'s undefined COVID-19 vaccine should be…
Moderna's COVID-19 vaccine becomes third vaccine approved for use in UK
The UK government has already approved COVID-19 vaccine developed by the University of Oxford and AstraZeneca as well as Pfizer-BioNTech for emergency use in the country
Laut Moderna-CEO: Impfstoff schützt „ein paar Jahre“ gegen Corona
Die Entwicklung von Impfstoffen und ihre Sicherheitsprüfung benötigt in der Regel Jahre — deshalb drängt auch die Frage nach ihrer Schutzdauer.
Chinese City Locked Down; Australia Tightens Rules: Virus Update
Track the latest developments in the global Covid-19 pandemic here.
Moderna's COVID-19 vaccine likely to be effective for couple of years, says CEO
The US biotech company, which stunned the world last year by coming up with a vaccine against the disease caused by the new coronavirus in just a few weeks, received approval for its shot from the European Commission on Wednesday
Pfizer vaccine appears effective against mutation in new coronavirus variants: Study
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
Did You Miss Out on the Chance for Big Gains from Arcturus Stock?
The biotech’s shares jumped by 299% last year, propelled by optimism about its COVID-19 vaccine candidate.
Moderna Coronavirus Vaccine Approved in Europe
The vaccine can now be distributed and administered throughout the 27-country European Union.
Europe prepares for Moderna vaccine rollout as fears grow over virus variants By Reuters
Europe prepares for Moderna vaccine rollout as fears grow over virus variants
4 Health Care Stocks to Consider as Covid-19 Vaccine Distribution Continues
4 Health Care Stocks to Consider as Covid-19 Vaccine Distribution Continues, Stocks: BIIB,CVS,HUM,UHS,PFE,BNTX,MRNA,WBA, release date:Jan 06, 2021
Corona-Impfstoff von Moderna: Der zweite Hoffnungsträger
Europa hat einen zweiten Corona-Impfstoff: Die EU-Kommission hat das Präparat des amerikanischen Herstellers Moderna freigegeben. Kann…
Biotech Stock Roundup: MRNA’s COVID-19 Vaccine Updates & Other Pipeline Updates
The biotech sector was in focus last week with COVID-19 vaccine study updates from Moderna (MRNA) and other regulatory updates.
Moderna : European Commission Authorizes COVID-19 Vaccine Moderna in Europe
Authorization follows European Medicines Agency recommendation of COVID-19 Vaccine Moderna
European Commission has secured 160 million doses; first deliveries to countries will begin next week
… | January 6, 2021
2021 Could Be Novavax’s Year
Novavax (NASDAQ: NVAX) saw its stock gain over 3,000% last year. But it could have even more room to run as the market will get only crazier for vaccines …
Auch Moderna-Impfstoff in der EU zugelassen
(Ausführliche Fassung) – Als zweiter Corona-Impfstoff ist ab sofort auch das Mittel des US-Herstellers Moderna in der Europäischen Union zugelassen. Dies entschied die EU-Kommission am Mittwoch auf Empfehlung der…
Covid-19 Vaccine Rollout by CVS at Nursing Homes Off to a Slow Start
Hesitancy on the part of long-term-care-facility staffers to receive Covid-19 vaccinations is slowing the rollout of the shots to the nation’s nursing homes and assisted-living centers.
The Opportunity May Just Be Getting Started For Moderna
If you’re interested in buying this dip in Moderna, it’s important to understand that you’re investing in mRNA technology more than MRNA stock.
EU regulator approves Moderna vaccine as fears mount over virus variants
Read more about EU regulator approves Moderna vaccine as fears mount over virus variants on Business Standard. Vaccinating the European Union’s 450 million people could be crucial to ending a pandemic that has killed almost 1.9 million people globally
Has COVID Research Resulted in Game-Changing Innovations for Other Diseases?
Not yet. But there’s more to the story.
The Covid vaccine’s long journey: How doses get from the manufacturing plant to your arm
The Covid vaccine’s distribution involves complex logistics, from cooling it with dry ice to making sure snowstorms don’t delay shipping.
Moderna’s Covid-19 Vaccine Is Cleared in Europe
The European Union’s main drug regulator cleared Moderna’s Covid-19 vaccine for use, offering the region a second shot to fight the coronavirus.
EMA Committee Recommends Conditional Approval Of Moderna’s Coronavirus Vaccine
Moderna Inc (NASDAQ: MRNA) is close to getting its fourth regulatory nod for mRNA-1273, its vaccine candidate against SARS-CoV-2.
What Happened: The …
2 Coronavirus Stocks That Will Keep Winning in 2021
The U.S. is focusing on coronavirus testing and vaccination. And that’s exactly where these companies excel.
European regulator approves Moderna Covid vaccine for use in the EU
Moderna’s vaccine is the second to be greenlit by European regulators.